These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30053213)
1. INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial. Dupont C; Vermandel M; Leroy HA; Quidet M; Lecomte F; Delhem N; Mordon S; Reyns N Neurosurgery; 2019 Jun; 84(6):E414-E419. PubMed ID: 30053213 [TBL] [Abstract][Full Text] [Related]
2. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial. Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128 [TBL] [Abstract][Full Text] [Related]
3. Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240). Peciu-Florianu I; Vannod-Michel Q; Vauleon E; Bonneterre ME; Reyns N J Neurooncol; 2024 Jul; 168(3):495-505. PubMed ID: 38753093 [TBL] [Abstract][Full Text] [Related]
4. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study. da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282 [TBL] [Abstract][Full Text] [Related]
5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
6. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783 [TBL] [Abstract][Full Text] [Related]
7. Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport. Finlayson L; McMillan L; Suveges S; Steele D; Eftimie R; Trucu D; Brown CTA; Eadie E; Hossain-Ibrahim K; Wood K J Biomed Opt; 2024 Feb; 29(2):025001. PubMed ID: 38322729 [TBL] [Abstract][Full Text] [Related]
8. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma. Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201 [TBL] [Abstract][Full Text] [Related]
9. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. Coburger J; Hagel V; Wirtz CR; König R PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409 [TBL] [Abstract][Full Text] [Related]
10. [Progression of basic research, clinical application of photodynamic therapy and fluorescence-guided surgery in glioma treatment]. Li X; Feng H; Li F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):360-367. PubMed ID: 29774871 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. Inogés S; Tejada S; de Cerio AL; Gállego Pérez-Larraya J; Espinós J; Idoate MA; Domínguez PD; de Eulate RG; Aristu J; Bendandi M; Pastor F; Alonso M; Andreu E; Cardoso FP; Valle RD J Transl Med; 2017 May; 15(1):104. PubMed ID: 28499389 [TBL] [Abstract][Full Text] [Related]
12. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Eljamel MS; Goodman C; Moseley H Lasers Med Sci; 2008 Oct; 23(4):361-7. PubMed ID: 17926079 [TBL] [Abstract][Full Text] [Related]
13. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM). Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510 [TBL] [Abstract][Full Text] [Related]
14. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542 [TBL] [Abstract][Full Text] [Related]
15. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704 [TBL] [Abstract][Full Text] [Related]
16. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery. Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215 [TBL] [Abstract][Full Text] [Related]